Death receptor-ligand systems in cancer, cell death, and inflammation - Wikidata - awgldk - TriplyDB

Death receptor-ligand systems in cancer, cell death, and inflammation

Death receptor-ligand systems in cancer, cell death, and inflammation

http://www.wikidata.org/entity/Q26865568

about

Molecular crosstalk between apoptosis, necroptosis, and survival signaling Ubiquitin-Mediated Regulation of Cell Death, Inflammation, and Defense of Homeostasis Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)The Janus Face of Death Receptor Signaling during Tumor Immunoediting Linear ubiquitination in immunity Novel CHOP activator LGH00168 induces necroptosis in A549 human lung cancer cells via ROS-mediated ER stress and NF-κB inhibition Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis.H-Ras regulation of TRAIL death receptor mediated apoptosis The use of a stably expressed FRET biosensor for determining the potency of cancer drugs.Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death.Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor.Actein Inhibits Cell Proliferation and Migration in Human Osteosarcoma.Cardiolipin or MTCH2 can serve as tBID receptors during apoptosis Caspase-8: not so silently deadly.Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review.Autophagy as a pro-death pathway.TRAIL-based therapy in pediatric bone tumors: how to overcome resistance.Surviving apoptosis: life-death signaling in single cells.Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities.Rational combination strategies to enhance venetoclax activity and overcome resistance in hematologic malignancies.Thermoregulation as a disease tolerance defense strategy.The cellular autophagy/apoptosis checkpoint during inflammation.A role for TRAIL/TRAIL-R2 in radiation-induced apoptosis and radiation-induced bystander response of human neural stem cells Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.Cell-Extrinsic TNF Collaborates with TRIF Signaling To Promote Yersinia-Induced Apoptosis.Therapeutic applications of histone deacetylase inhibitors in sarcoma.Hepatocellular carcinoma repression by TNFα-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization.Silencing of karyopherin α2 inhibits cell growth and survival in human hepatocellular carcinoma Interleukin-10 plays a key role in the modulation of neutrophils recruitment and lung inflammation during infection by Streptococcus pneumoniae.Proapoptotic CD95L levels in normal human serum and sera of breast cancer patients.LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer A validated, transitional and translational porcine model of hepatocellular carcinoma.Radiation-induced glioblastoma signaling cascade regulates viability, apoptosis and differentiation of neural stem cells (NSC).Marine Sponge Natural Products with Anticancer Potential: An Updated Review.JNK-signaling: A multiplexing hub in programmed cell death.Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies?Tissue-Resident Cytolytic Innate Lymphocytes in Cancer.B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.

P2860

Q26745680-E471F4DE-A17A-46F4-B002-F70F12B834E4 Q26782575-1A9CDE18-753E-45FE-93F8-683B3D7EE84D Q26859211-CD60975D-37AC-434F-A9F9-9CB94999ABFD Q28070036-DB545A1D-AAB5-45C5-9B24-367E13BEB6D2 Q28082899-29F3CACA-7DF0-439B-A572-BE9E08AE1BEE Q28822272-7B845026-ECB9-4F48-8B8E-CC1A4090E3A8 Q30408769-CF01D522-86FD-40E4-8980-4FD27AC3D6C0 Q33912038-7B1730C0-1827-480F-9A90-87B42570E241 Q34104161-0BFED261-41ED-431A-A9B1-11AA1C2A02A3 Q35238143-75FFD07F-C2E2-49ED-9A07-927465B1981C Q36125103-3906C37C-6791-41AE-8137-8FEA59C13763 Q36600300-164078A3-ADBD-4F24-9A64-7384DF8EB754 Q37032178-37DE4641-EB04-41F7-B429-F71B6C896D0C Q37098808-6FCB19D4-5162-4FC3-B913-992ED39D5DFE Q37625431-A7B11D08-AF83-4676-8682-CFF0EF78FBD0 Q38178160-60792B88-67C8-4D33-A3E1-B879CD584C37 Q38261558-469D624C-8DB9-493C-8A1F-9304E7319D60 Q38352891-5FAF656E-F152-412B-8A10-C440B7DC18B2 Q38446898-70D8CF6A-A7DE-45E4-91B8-AC966387BC39 Q38503469-7A8DE240-947A-4664-BA00-30299729D4D7 Q38575137-992CE519-056C-44CB-8891-BC50EC900B42 Q38637652-00A27A73-B52A-4188-B534-4A19C0C6DF37 Q38999142-BEC355B6-8B45-4356-B037-9C567E77C97D Q39005984-F205208A-18CC-469C-8205-6BE05BA4BB83 Q39070728-E3FF3694-EADF-4EA6-B853-3C3A7332C15C Q39247899-8F42C2A9-3E64-4860-A537-AACD8EA54A27 Q39297992-C7A63995-0A0D-4A85-94BD-B222C6DAEF6E Q39450827-F92FE923-F085-4938-967B-5071C647E587 Q39767815-948023BF-B7B3-4865-9C43-FA97084A9584 Q41055921-8CE80191-6E10-4592-ACB7-1548C505AF37 Q41191945-78545A45-4901-4514-B421-D25DDB3AD290 Q41626977-13CF4DD2-DC91-4AC8-B364-9B8378D209D4 Q41949682-F22CB598-42A1-470D-8899-195C01EFB5DF Q41985448-62AF9867-A26F-4EED-8EA8-7EF32BFAA7C8 Q42117551-7828CE49-03A2-4893-A37A-70613040E472 Q43245354-2CFAC39A-72FC-4189-BE0E-93B3009B1E26 Q47095837-89208E79-83AC-4D60-8F49-1D245B658177 Q47742909-F42CB765-B5A6-4DB9-A04A-2DF001E9F1A3 Q50133227-CFE9F45B-68A8-4609-BE06-E31B856B7D7C Q50134139-981481F7-9ADD-4647-8BA2-8427406E064F

P2860

Death receptor-ligand systems in cancer, cell death, and inflammation

http://www.wikidata.org/entity/Q26865568

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Death receptor-ligand systems in cancer, cell death, and inflammation

@ast

Death receptor-ligand systems in cancer, cell death, and inflammation

@en

Death receptor-ligand systems in cancer, cell death, and inflammation

@nl

type

label

Death receptor-ligand systems in cancer, cell death, and inflammation

@ast

Death receptor-ligand systems in cancer, cell death, and inflammation

@en

Death receptor-ligand systems in cancer, cell death, and inflammation

@nl

prefLabel

Death receptor-ligand systems in cancer, cell death, and inflammation

@ast

Death receptor-ligand systems in cancer, cell death, and inflammation

@en

Death receptor-ligand systems in cancer, cell death, and inflammation

@nl

P1433

Q26865568-604240C5-DD48-4735-BED1-1082D331E8E0

P1476

Q26865568-6A648953-49D0-41DF-93ED-C60CAA9C909B

P2093

Q26865568-33AFFC1A-B57F-41DA-9868-2DBA244976DC

P2860

Q26865568-0381C9DC-9C5C-4072-BC12-09F898CDC079

Q26865568-072EC009-E84F-45B8-9E76-A6FC955DB799

Q26865568-0740A690-FF65-46B0-9C7D-08B18B6850D4

Q26865568-07D0897E-655E-4EBA-9455-5894200C7F4A

Q26865568-0BBDD965-F1A5-450D-8A50-B89883738B9C

Q26865568-0CF34869-4235-4FDC-98D6-D057F4EB74F8

Q26865568-0D46F13D-9EBF-4A0F-8966-8CC73E6B07CA

Q26865568-0F058D91-CB9F-4DCC-8956-8225460A90AD

Q26865568-0F30D859-512C-4A5E-AF3D-11AFC510EB66

Q26865568-1069426E-DB47-4365-95B0-088DAAE5F760

P304

Q26865568-9C8F2951-B4B0-4487-884A-28453E92BBAE

P31

Q26865568-F2560493-6225-426C-86FA-DF375EA6B563

P3181

Q26865568-8188A95C-4078-4CC6-8A88-57EBE098031D

P356

Q26865568-F6E2241C-869A-4CC1-B48C-EFF6949AA3DD

P407

Q26865568-4B2DE056-3BB9-4455-B38D-3112C6A1A8ED

P433

Q26865568-CFEAB35F-DB9D-4526-B395-05215B97FE69

P478

Q26865568-1250DBEB-54F5-4366-8999-437D2B955752

P577

Q26865568-922808A2-1545-4029-A1B0-940BB26422C6

P5875

Q26865568-41113F35-EF44-4114-9294-51D418CDE8A1

P698

Q26865568-78ADF041-B026-4A1B-AE9C-EB830441B1A2

P921

Q26865568-C2314A91-CD32-484E-B4B5-8D54C2492761

P932

Q26865568-2713E58C-AECC-4523-8793-22B0CBEEBA70

P3181

P356

CSHPERSPECT.A008698

P1433

Cold Spring Harbor Perspectives in Biology

P1476

Death receptor-ligand systems in cancer, cell death, and inflammation

@en

P2093

H. Walczak

http://www.w3.org/2001/XMLSchema#string

P2860

APP binds DR6 to trigger axon pruning and neuron death via distinct caspases

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

Yes and PI3K bind CD95 to signal invasion of glioblastoma

Linear ubiquitination prevents inflammation and regulates immune signalling

Molecular cloning and expression of a receptor for human tumor necrosis factor

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

The receptor for the cytotoxic ligand TRAIL

P304

a008698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1657020

http://www.w3.org/2001/XMLSchema#string

P356

10.1101/CSHPERSPECT.A008698

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236603689

http://www.w3.org/2001/XMLSchema#string

P698

23637280

http://www.w3.org/2001/XMLSchema#string

P921

P932

3632055

http://www.w3.org/2001/XMLSchema#string